University of Michigan researchers have discovered that a single dose of a psychedelic compound can enhance cognitive ...

Copper gained, supported by the weaker dollar. Industrial-metal prices were under pressure recently due to growing demand headwinds, said ANZ Research analysts. The current tariff turmoil has dented ...

Bright Minds Biosciences has a decent balance sheet, with roughly $40.3 million in cash. Click here to find out why I rate ...

Results were announced from a phase 3 trial evaluating solriamfetol for major depressive disorder with/without severe excessive daytime sleepiness.

Ax­some Ther­a­peu­tics said Tues­day that a Phase 3 tri­al for its nar­colep­sy drug Sunosi failed to meet its pri­ma­ry goal in ma­jor de­pres­sive dis­or­der. … ...

There are a variety of mental health symptoms that can vary by menstrual phase and by person. Clinical psychologist Crystal Schiller, PhD, director of the UNC Center for Women’s Mood Disorders ...

There are a variety of mental health symptoms that can vary by menstrual phase and by person. Clinical psychologist Crystal Schiller, PhD, director of the UNC Center for Women’s Mood Disorders ...

You bet! There are a variety of mental health symptoms that can vary by menstrual phase and by person. Clinical psychologist Crystal Schiller, PhD, director of the UNC Center for Women’s Mood ...

A new study found that more than half of US adults encounter some form of discrimination, and that this mistreatment may fuel higher chances of depression and/or anxiety among specific racial and ...

Bipolar disorder is marked by alternating episodes of mania or hypomania and phases of depression, impacting one’s ability to function, regulate emotions, and maintain social relationships. Although ...

Lipocine has announced the commencement of a randomised Phase III clinical trial of LPCN 1154, an oral formulation of brexanolone, being developed for treating postpartum depression (PPD).